<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04190082</url>
  </required_header>
  <id_info>
    <org_study_id>YUMC-2019-11-001</org_study_id>
    <nct_id>NCT04190082</nct_id>
  </id_info>
  <brief_title>The Effect of Bispectral Index Monitoring on Recovery From Deep Sedation</brief_title>
  <official_title>The Effect of Bispectral Index Monitoring on the Speed of Recovery From Deep Propofol Sedation in Children With Cerebral Palsy - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yeungnam University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yeungnam University College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare BIS (bispectral index) monitoring and clinical
      sedation scale assessment on the recovery time and propofol usage from deep propofol sedation
      in children with cerebral palsy who received botulinum toxin injection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After arrival in the preoperative holding area, children were randomly allocated into two
      groups using a computer-generated random assignment scheme. Five minutes before propofol
      sedation, remifentanil is administered intravenously at 0.025 μg / kg / min for analgesic
      effect and continued throughout the sedation process until just before the end of the
      procedure. Five minutes after remifentanil administration, 2 mg / kg of propofol mixed with 1
      mg / kg of lidocaine was administered over 30 seconds, followed by continuous infusion at 100
      μg / kg / min. Group C is monitored using UMSS(University of Michigan Sedation Scale) scores
      every three minutes, and group B is monitored using BIS score until deep sedation. Deep
      sedation is defined based on UMSS score of 3-4 and BIS score of 65 ± 5. If the sedation score
      is determined to have reached a deep sedation, a botulinum toxin injection is given by a
      practitioner blind to how to assess the depth of sedation. Independent investigator who is
      blind to group assignement assesses the oxygen saturation, respiration, and blood pressure,
      recovery time from sedation, and adverse events during and after sedation.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 10, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>recovery</measure>
    <time_frame>Immediately after discontinuation of propofol infusion used for botulinum toxin injection</time_frame>
    <description>Time taken to recover based on the Physiological CBD score (&gt;12) from deep sedation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Propofol dose</measure>
    <time_frame>Immediately after discontinuation of propofol infusion used for botulinum toxin injection</time_frame>
    <description>Amount of propofol to maintain deep sedation for botulinum toxin injection</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Group Control</arm_group_label>
    <description>Group who maintains deep sedation using the University of Michigan sedation scale (UMSS) score.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group BIS</arm_group_label>
    <description>Group who maintain deep sedation using Bispectral Index (BIS) score.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        children with spastic cerebral palsy primary care clinic (rehabilitation)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  3-12 years old children with spastic cerebral palsy receiving botulinum toxin
             injection with deep sedation

          -  American Society of Anesthesiologists Physical Status 1-2

        Exclusion Criteria:

          -  Body mass index &gt; 30 kg/m2

          -  unstable heart disease

          -  Anticipated difficult airway including congenital facial or airway anomaly

          -  Recent upper respiratory tract infection ( &lt; 2 weeks)

          -  Gastroesophageal reflux

          -  Allergy history to propofol, remifentanil or any drug used during procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung Mee Jung, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yeungnam University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sung Mee Jung, MD,PhD</last_name>
    <phone>+82-53-620-3368</phone>
    <email>applejsm@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sung Min Jeon, MD</last_name>
    <phone>+82-10-9964-0863</phone>
    <email>sminjun@ynu.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Location Yeungnam University Hospita</name>
      <address>
        <city>Daegu</city>
        <zip>42415</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Sung Mee Jung, MD, PhD</last_name>
      <phone>+82-53-620--3368</phone>
      <email>applejsm@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Choudhry DK, Brenn BR. Bispectral index monitoring: a comparison between normal children and children with quadriplegic cerebral palsy. Anesth Analg. 2002 Dec;95(6):1582-5, table of contents.</citation>
    <PMID>12456420</PMID>
  </results_reference>
  <results_reference>
    <citation>Malviya S, Voepel-Lewis T, Tait AR. A comparison of observational and objective measures to differentiate depth of sedation in children from birth to 18 years of age. Anesth Analg. 2006 Feb;102(2):389-94.</citation>
    <PMID>16428530</PMID>
  </results_reference>
  <results_reference>
    <citation>Saricaoglu F, Celebi N, Celik M, Aypar U. The evaluation of propofol dosage for anesthesia induction in children with cerebral palsy with bispectral index (BIS) monitoring. Paediatr Anaesth. 2005 Dec;15(12):1048-52.</citation>
    <PMID>16324022</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 4, 2019</study_first_submitted>
  <study_first_submitted_qc>December 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2019</study_first_posted>
  <last_update_submitted>December 8, 2019</last_update_submitted>
  <last_update_submitted_qc>December 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yeungnam University College of Medicine</investigator_affiliation>
    <investigator_full_name>Sung Mee Jung</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cerebral palsy</keyword>
  <keyword>Botulinum toxin</keyword>
  <keyword>Bispectral index monitor</keyword>
  <keyword>Deep sedation</keyword>
  <keyword>Recovery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no plan to share our data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

